Page 21 - merged

Index

November 22, 2015 (Sunday)

S101- WPAIC Workshop

Ketamine Tiger and Trainer

S101-1 High Prevalence of Major Depression among Treatment-Seeking Ketamine Dependent Patients--- A Hospital-Based

Study in Taipei City

Lian-Yu Chen (Taiwan)

S101-2 Neurocognitive Measures of Ketamine Users and Methamphetamine Users

Chih-Ken Chen (Taiwan)

S101-3 Reliability and Validity of the Severity of Dependence Scale in a Chinese Sample of Treatment-Seeking Ketamine Users

Chi-Kwong Tung (Hong Kong)

S101-4 The Neuroendocrine Alterations in Treatment-Seeking Ketamine Dependent Patients

Ming-Chyi Huang (Taiwan)

S102- WPAIC Symposium

Psychological Assessment and Intervention in Children with ADHD

S102-1 ADHD Family Support Model in Central Taiwan

Vincent Chin-Hung Chen (Taiwan)

S102-2 The Effect of a Parent-Child Interaction Group for Children with ADHD in Taiwan

Yi-Chen Lee (Taiwan)

S102-3 Self-Esteem and its Correlates among Adolescents with Attention-Deficit/Hyperactivity Disorder

Wen-Jiun Chou (Taiwan)

S102-4 Understanding ADHD, Emotional Difficulties, Parenting, Family Function and Social Adjustment: A Structural Equation

Yi-Lung Chen (Taiwan)

S103- AsCNP Symposium

Opportunities and Challenges for Asian Countries in the New Psychiatric Drug Development: Views from an Global Contract

Research Organization

S103-1 Asia's Role in Global Drug Development and the Experiences of Psychiatry

Doug Williamson (USA)

S103-2 Environments and Experiences for Global Drug Development and the Story of Psychiatry: Taiwan and China

Chaucer Chiao-Hsiang Lin (Taiwan)

S103-3 Environments and Experiences for Global Drug Development and the Story of Psychiatry: Japan and South Korea

Yukiya Sasaki (Japan)

S103-4 Environments and Experiences for Global Drug Development and the Story of Psychiatry: Singapore and Hong Kong

Angelitojonas Kalaw (Singapore)

S104- AsCNP Symposium

Genome-Wide Association Studies (GWAS) on Psychiatry in Asian Populations

S104-1 GWAS of Lithium Sensitivity in Patients with Bipolar Disorder

Chau-Shoun Lee (Taiwan)

S104-2 Genome-Wide Association Studies and Pathway-Network based Analyses for Subtypes of Bipolar Disorder

Po-Hsiu Kuo (Taiwan)

S104-3 GWAS of Substance Dependence

Ichiro Sora (Japan)

S104-4 Genome-Wide Association Study Identifies A Potent Locus Associated with Human Opioid Sensitivity

Daisuke Nishizawa (Japan)

S105- AsCNP Symposium

Ketamine, A Rapid-Acting Antidepression Agent, in Treating Resistant Depression in Taiwan: From Neuropharmacology, Clinical

Trial, Brain Imaging to Animal Model Development

S105-1 Neuropsychopharmacology of Ketamine as a Rapid Acting Anti-Depression and Anti-Suicidality Agent

Guang Chen (USA)

S105-2 Fast Antidepressant Efficacy of a Single Low-Dose Ketamine Infusion in Treating Resistant Depression: A Double-Blind

and Randomized-Controlled Trial

Tung-Ping Su (Taiwan)

S105-3 The Effect of Ketamine on the Metabolism and Functional Connectivity of Prefrontal Cortex-Related Circuits in

Treatment-Resistant Depression: A Double-Blind, Placebo-Controlled, Randomized, Longitudinal Imaging Study

Mu-Hong Chen (Taiwan)

S105-4 Effects of Ketamine on the Emotional Behavior and Electrophysiology of Mice

Chen-Jee Hong (Taiwan)

- 20 -